<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02848287</url>
  </required_header>
  <id_info>
    <org_study_id>AJIRB-MED-DRU-16-061</org_study_id>
    <nct_id>NCT02848287</nct_id>
  </id_info>
  <brief_title>Influence of 0.75% Ropivacaine Topicalization on Emergence Agitation in Children</brief_title>
  <official_title>Influence of 0.75% Ropivacaine Topicalization on Emergence Agitation in Preschool-aged Children Undergoing Adenotonsillectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ajou University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ajou University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Emergence agitation (EA) is highly prevalent in children after surgery. Risk factors for EA
      are Eye, nose and throat (ENT) surgery, preoperative anxiety, postoperative pain. There are
      several preventive strategies but none of them completely prevent EA.

      Topical application of ropivacaine can reduce post-tonsillectomy pain. Therefore, it might
      reduce the incidence of postoperative EA.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Anticipated">August 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Paediatric anesthesia emergence delirium scale (PAED) score at PACU admission</measure>
    <time_frame>1 min after postanesthesia care unit (PACU) admission</time_frame>
    <description>PAED score is assessed</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Face legs activity cry consolability (FLACC) score</measure>
    <time_frame>1 min after postanesthesia care unit (PACU) admission</time_frame>
    <description>FLACC score is assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PAED score 10 min after PACU admission</measure>
    <time_frame>10 min after postanesthesia care unit (PACU) admission</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PAED score 20 min after PACU admission</measure>
    <time_frame>20 min after postanesthesia care unit (PACU) admission</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PAED score 30 min after PACU admission</measure>
    <time_frame>30 min after postanesthesia care unit (PACU) admission</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FLACC score 10 min after PACU admission</measure>
    <time_frame>10 min after postanesthesia care unit (PACU) admission</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FLACC score 20 min after PACU admission</measure>
    <time_frame>20 min after postanesthesia care unit (PACU) admission</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FLACC score 30 min after PACU admission</measure>
    <time_frame>30 min after postanesthesia care unit (PACU) admission</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Tonsillitis</condition>
  <arm_group>
    <arm_group_label>Normal Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>1*2 gauze is soaked with 5 cc of 0.9 % normal saline, applied in tonsillar fossae for 3 min, then removed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ropivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1*2 gauze is soaked with 5 cc of 0.75% ropivacaine, applied in tonsillar fossae for 3 min, then removed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>normal saline</intervention_name>
    <description>1*2 gauze is soaked with 5 cc of 0.9 % normal saline, applied in tonsillar fossae for 3 min, then removed.</description>
    <arm_group_label>Normal Saline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ropivacaine</intervention_name>
    <description>1*2 gauze is soaked with 5 cc of 0.75% ropivacaine, applied in tonsillar fossae for 3 min, then removed.</description>
    <arm_group_label>Ropivacaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of anesthesiologist physical status class I/II

          -  tonsillectomy or adenotonsillectomy under general anesthesia

        Exclusion Criteria:

          -  obstructive sleep apnea

          -  developmental delay attention deficit hyperactivity disorder, allergy to local
             anesthetics, convulsion disorder
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Go Un Roh, MD</last_name>
    <phone>82-31-219-6435</phone>
    <email>gone7968@aumc.ac.kr</email>
  </overall_contact>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 26, 2016</study_first_submitted>
  <study_first_submitted_qc>July 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 28, 2016</study_first_posted>
  <last_update_submitted>July 26, 2016</last_update_submitted>
  <last_update_submitted_qc>July 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ajou University School of Medicine</investigator_affiliation>
    <investigator_full_name>Go Un Roh</investigator_full_name>
    <investigator_title>Clinical assistant professor, primary investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emergence Delirium</mesh_term>
    <mesh_term>Tonsillitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

